Advertisement

Estimating willingness to pay for diabetes complications

Published:October 14, 2022DOI:https://doi.org/10.1016/j.pcd.2022.09.012

      Highlights

      • Maximum willingness to pay (WTP) for a health benefit is connected to perceived value.
      • Most diabetic patients are willing to pay for a preventive package.
      • The most WTP was stated for a preventive package that reduces the chance of blindness in diabetes.
      • The attitude of diabetic patients toward diabetes still needs further investigation.

      Abstract

      Background

      Maximum willingness to pay (WTP) for a health benefit is connected to perceived value. This two-center study aims to analyse diabetic patients' WTP for obtaining a specific preventive treatment package to reduce severe diabetic complications and determine the factors that impact this value.

      Methods

      This cross-sectional research included 557 diabetics from two cities in Iran. The WTP for a preventative package minimising major diabetes complications (cardiovascular, renal, ocular, and diabetic foot) by 50% and 100% was tested using eight scenarios. The Diabetes Attitude Scoring Questionnaire (DAS-3) was used to examine patient attitudes toward diabetes. To determine WTP, a two-stage hurdle method was used. The level of significance was fixed to 0.05.

      Results

      Around 80% of 557 people interviewed (mean age 47.54) stated they wanted to pay for a diabetes prevention package. This package's WTP varied from 169.4 to $374.5 depending on the complication and degree of risk reduction. The largest value diabetic patients willing to pay for preventative packages that reduce the chance of blindness was reported, while the lowest cost was stated for the diabetic foot. WTP is influenced by wealth, location of study, marital status, and attitude toward special training, but not by the type of diabetes, inpatient or outpatient setting, or the complications diabetes patients are impacted by. Patients' diabetes attitudes were mainly negative. The score of the attitude of patients towards diabetes was generally suboptimal.

      Conclusion

      Most diabetic patients were willing to pay for a preventive package and this value was not affected by the type of diabetes and its severity. Our research found that diabetic individuals are willing to pay the most for a preventative package that reduces the chance of blindness, and the least for diabetic foot care. WTP can help health officials allocate resources and manage budgets. The attitude of diabetic patients toward diabetes still needs further interventional research, however.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wild S.
        • Roglic G.
        • Green A.
        • Sicree R.
        • King H.
        Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030.
        Diabetes Care. 2004; 27: 1047-1053
        • Javanbakht M.
        • Mashayekhi A.
        • Baradaran H.R.
        • Haghdoost A.
        • Afshin A.
        Projection of diabetes population size and associated economic burden through 2030 in Iran: evidence from micro-simulation markov model and bayesian meta-analysis.
        PLoS One. 2015; 10: e0132505e
        • Haghdoost A.
        • Rezazadeh Kermani M.
        • Sadghirad B.
        • Baradaran H.
        Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis.
        EMHJ. 2009; 15: 591-599
        • American Diabetes A.
        Diagnosis and classification of diabetes mellitus.
        Diabetes Care. 2010; 33: S62-S69
        • Young B.A.
        • Maynard C.
        • Reiber G.
        • Boyko E.J.
        Effects of ethnicity and nephropathy on lower-extremity amputation risk among diabetic veterans.
        Diabetes Care. 2003; 26495501
        • Selby J.V.
        • Zhang D.
        Risk factors for lower extremity amputation in persons with diabetes.
        Diabetes Care. 1995; 18: 509-516
        • Von Korff M.
        • Katon W.
        • Lin E.H.B.
        • Simon G.
        • Ciechanowski P.
        • Ludman E.
        • et al.
        Work disability among individuals with diabetes.
        Diabetes Care. 2005; 28: 1326-1332
        • Simon G.E.
        • Katon W.J.
        • Lin E.H.B.
        • Ludman E.
        • VonKorff M.
        • Ciechanowski P.
        • et al.
        Diabetes complications and depression as predictors of health service costs.
        Gen. Hosp. Psychiatry. 2005; 27: 344-351
        • Hoerger T.J.
        • Harris R.
        • Hicks K.A.
        • Donahue K.
        • Sorensen S.
        • Engelgau M.
        Screening for Type 2 diabetes mellitus: a cost-effectiveness analysis.
        Ann. Intern Med. 2004; 140: 689-699
        • Hogan P.
        • Dall T.
        • Nikolov P.
        Economic costs of diabetes in the U.S. in 2002.
        Diabetes Care. 2003; 26: 917-932
        • Davari M.
        • Boroumand Z.
        • Amini M.
        • Aslani A.
        • Hosseini M.
        The direct medical costs of outpatient cares of type 2 diabetes in Iran: a retrospective study.
        Int J. Prev. Med. 2016; 7: 72
        • Javanbakht M.
        • Baradaran H.R.
        • Mashayekhi A.
        • Haghdoost A.A.
        • Khamseh M.E.
        • Kharazmi E.
        • et al.
        Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
        PLoS One. 2011; 6: e26864e
        • O'Brien B.
        • Gafni A.
        When do the "dollars" make sense?:toward a conceptual framework for contingent valuation studies in health care.
        Med Decis. Mak. 1996; 16: 288-299
        • Chang K.
        Comorbidities, quality of life and patients' willingness to pay for a cure for type 2 diabetes in Taiwan.
        Public Health. 2010; 124: 284-294
        • Moradi N.
        • Rashidian A.
        • Mohammadi T.
        • Alamdari S.
        • Oliaei Manesh A.
        Willingness to pay for one quality adjusted life years in patients with diabetes.
        Value Health. 2015; 18: A616A7
        • Ghaffari S.
        • Hashemi S.E.
        • Atabaki H.
        The national financial burden of hospitalization of diabetes in Iran.
        J. Clin. Res. Gov. 2012; 1: 16-21
        • Sajjadi F.
        • Moradi-Lakeh M.
        • Nojomi M.
        • Baradaran H.R.
        • Azizi F.
        Health system responsiveness for outpatient care in people with diabetes Mellitus in Tehran.
        Med J. Islam Repub. Iran. 2015; 29: 293
        • Lankarani K.B.
        • Ghahramani S.
        • Moradi N.
        • et al.
        Willingness-to-pay for one quality-adjusted life-year: a population-based study from Iran.
        Appl. Health Econ. Health Policy. 2018; 16: 837-846
        • Ghahramani S.
        • Ziar N.
        • Moradi N.
        • et al.
        Preserving natural teeth versus extracting them: a willingness to pay analysis.
        BMC Oral. Health. 2022; 22: 375
        • Anderson R.M.
        • Donnelly M.B.
        • Dedrick R.F.
        Measuring the attitudes of patients towards diabetes and its treatment.
        Patient Educ. Couns. 1990; 16: 231-245
        • Mahjouri M.Y.
        • Arzaghi S.M.
        • Qorbani M.
        • Nasli-Esfahani E.
        • Larijani B.
        Evaluation of psychometric properties of the third version of the Iranian Diabetes Attitude Scale (IR-DAS-3).
        J. Diabetes Metab. Disord. 2011; 10: 1-6
        • Meyer R.
        • Liebe U.
        Are the affluent prepared to pay for the planet? Explaining willingness to pay for public and quasi-private environmental goods in Switzerland.
        Popul Environ. 2010; 32: 42-65
        • Terwei A.
        • Zerbe S.
        • Zeileis A.
        • Annighöfer P.
        • Kawaletz H.
        • Mölder I.
        • et al.
        Which are the factors controlling tree seedling establishment in North Italian floodplain forests invaded by non-native tree species?.
        For. Ecol. Manag. 2013; 304: 192-203
        • Gerich J.
        • Moosbrugger R.
        • Heigl C.
        Health literacy and age-related health-care utilisation: a multi-dimensional approach.
        Ageing Soc. 2020; : 1-22
        • Cai Q.
        • Lee J.
        • Eluru N.
        • Abdel-Aty M.
        Macro-level pedestrian and bicycle crash analysis: Incorporating spatial spillover effects in dual state count models.
        Accid. Anal. Prev. 2016; 93: 14-22
        • Liu X.
        • Chen W.
        • Chen T.
        • Zhang H.
        • Zhang B.
        Marginal effects and incremental effects in two-part models for endogenous healthcare utilization in health services research.
        Health Serv. Outcomes Res. Methodol. 2020; 20: 111-139
        • Belotti F.
        • Deb P.
        • Manning W.G.
        • Norton E.C.
        2 pm: two-part models.
        Stata J. 2015; 15: 3-20
        • Wukich D.K.
        • Raspovic K.M.
        • Suder N.C.
        Patients with diabetic foot disease fear major lower-extremity amputation more than death.
        Foot Ankle Spec. 2018; 11: 17-21
        • Moradi N.
        • Rashidian A.
        • Rasekh H.R.
        • Olyaeemanesh A.
        • Foroughi M.
        • Mohammadi T.
        Monetary value of quality-adjusted life years (QALY) among patients with cardiovascular disease: a willingness to pay study (WTP).
        IJPR. 2017; 16: 823
        • Song H.J.
        • Lee E.-K.
        Evaluation of willingness to pay per quality-adjusted life year for a cure: a contingent valuation method using a scenario-based survey.
        Medicine. 2018; 97e12453
      1. Donaldson C., Baker R., Mason H., Pennington M., Bell S., Lancsar E., et al. European value of a quality adjusted life year—final publishable report 2010. Available from: research ncl ac uk/eurovaq/EuroVaQ_Final_Publishable_Report_and_Appendices pdf[Accessed November 18, 2012]. 2018.

        • Anderson R.M.
        • Donnelly M.B.
        • Dedrick R.F.
        Measuring the attitudes of patients towards diabetes and its treatment.
        Patient Educ. Couns. 1990; 16: 231-245
        • Guo X.H.
        • Yuan L.
        • Lou Q.Q.
        • Shen L.
        • Sun Z.L.
        • Zhao F.
        • et al.
        A nationwide survey of diabetes education, self-management and glycemic control in patients with type 2 diabetes in China.
        Chin. Med J. (Engl. ). 2012; 125: 4175-4180